Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07137312) titled 'Ex Vivo Expansion (ACT-X)' on Aug. 15.
Study Type: Observational
Primary Sponsor: Mayo Clinic
Condition:
Solid Tumor
Healthy
Intervention:
Procedure: Blood Draw
Recruitment Status: Not recruiting
Date of First Enrollment: October 2025
Target Sample Size: 20
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07137312
Published by HT Digital Content Services with permission from Health Daily Digest....